When was Retractable Technologies founded?

Retractable Technologies was founded in 1989 and raised its 1st funding round 31 years after it was founded.

Where is Retractable Technologies located?

Retractable Technologies is headquartered in Little Elm, United States. It is registered at Little Elm, Texas.

Who is the current CEO of Retractable Technologies?

Thomas Shaw of Retractable Technologies. They have also founded 1 company.

How many employees does Retractable Technologies have?

As of Jul 31, 2026, the latest employee count at Retractable Technologies is 113.

Is Retractable Technologies a funded company?

Retractable Technologies is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Jul 01, 2020.

When was the latest funding round of Retractable Technologies?

Retractable Technologies' latest funding was a $***** Grant (prize money) round on Jul 01, 2020, with participation from 1 investor.

What is the annual revenue of Retractable Technologies?

Annual revenue of Retractable Technologies is between $10M and $50M as on Dec 31, 2025

Where does Retractable Technologies rank among its competitors?

Retractable Technologies ranks 6th amongst 82 active competitors, of which 21 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Stable Pharma, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Retractable Technologies?

Retractable Technologies' top competitors include Crossject, Xeris Pharmaceuticals and KORU Medical Systems. Among them, Stable Pharma secured the most recent funding round in May, 2026.

Retractable Technologies - 2026 Company Profile, Team, Funding, Competitors & Financials

Retractable Technologies is a public company based in Little Elm (United States), founded in 1989 by Thomas Shaw. It operates as a Provides portfolio of smart syringes and needles to prevent from needle-stick injuries. Retractable Technologies has raised an undisclosed amount in funding. The company has 82 active competitors, including 21 funded and 8 that have exited. Its top competitors include companies like Crossject, Xeris Pharmaceuticals and KORU Medical Systems.

Company Details

Provides portfolio of smart syringes and needles to prevent needle-stick injuries. The company offers VanishPoint Syringes, which are available in a range of sizes, needle gauges, and needle lengths. The needle is automatically retracted directly from the patient into the barrel of the syringe when the plunger handle is fully depressed. Another product, the EasyPoint retractable needles feature automated retraction technology and pre-removal capability.

Website: retractable.com
Email ID: *****@retractable.com
Phone Number: +1 **********
Registered Address: Little Elm, Texas

Key Metrics

Founded Year

1989

Location

Little Elm, United States

Stage

Public

Latest Funding Round

Grant (prize money), Jul 01, 2020, $*****

Investors

USAGov

Ranked

6^th among 82 active competitors

Annual Revenue

$10M - $50M as on Dec 31, 2025

Employee Count

113 as on Jul 31, 2026

Similar Companies

KORU Medical Systems & 57 more

Exit Details

Public

View Retractable Technologies' full profile

Retractable Technologies is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
RETRACTABLE TECHNOLOGIES INC CIN: 946563 , United States, Active		$10M - $50M (As on Dec 31, 2025)	198 (As on Dec 31, 2022)	-
RETRACTABLE TECHNOLOGIES, INC CIN: 752599762 , United States, Active	Dec 26, 999	-	170 (As on Dec 31, 2024)	-
Retractable Technologies, Inc. CIN: 80609598 , United States, Active	Oct 12, 2011	-	-	-

Retractable Technologies got listed on May 04, 2001.

Click here to take a look at Retractable Technologies's IPO in detail

Retractable Technologies has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Jul 01, 2020 for $*****. 1 investor participated in its latest round. Retractable Technologies has 1 institutional investor.

Here is the list of recent funding rounds of Retractable Technologies:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2020	3463380	Grant (prize money)	5464183	3821634	3866393	2054891

Access funding benchmarks and valuations. Sign up today!

View details of Retractable Technologies's funding rounds and investors

The founders of Retractable Technologies is Thomas Shaw. Thomas Shaw is the CEO of Retractable Technologies.

Here are the details of Retractable Technologies' key team members:

Thomas Shaw: Founder & CEO of Retractable Technologies.

View details of Retractable Technologies's Founder profiles and Board Members

Retractable Technologies' employee count trend

Retractable Technologies has 113 employees as of Jul 26. Here is Retractable Technologies's employee count trend over the years:

Employee count trend for Retractable Technologies

Uncover Retractable Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Retractable Technologies include Crossject, Xeris Pharmaceuticals and KORU Medical Systems. Here is the list of Top 10 competitors of Retractable Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Crossject 2001, Dijon (France), Public	Needle-free self-injectable drugs	$40.3M	Rothschild & Co, GSK & 5 others	60/100
2nd	Xeris Pharmaceuticals 2005, Chicago (United States), Public	Developer of liquid-stable injectables for the delivery of drugs	$155M	Redmile Group, Central Texas Angel Network ... & 19 others	60/100
3rd	KORU Medical Systems 1980, City of Orange (United States), Public	Manufacturer of infusion systems and accessories for subcutaneous drug administration	-	-	55/100
4th	Stable Pharma 2011, Bath (United Kingdom), Series B	Developer of technology to store and deliver stable drugs and vaccines	$5M	Ascension, EIC Fund & 78 others	53/100
5th	Owen Mumford 1952, Oxford (United Kingdom), Acquired	Disposables for drug delivery and capillary blood sampling in a variety of therapeutic areas	-	Europa	52/100
6th	Retractable Technologies 1989, Little Elm (United States), Public	Provides portfolio of smart syringes and needles to prevent from needle-stick injuries	-	USAGov	51/100
7th	Ascilion 2012, Stockholm (Sweden), Series A	Developer of needles for drug delivery and fluid extraction	$2.23M	Nordstjernan, Marinvest & 2 others	48/100
8th	Flat Medical 2015, Oakland (United States), Series C	Manufacturer of epidural injection	-	Taiwania Capital, National Development Council ... & 4 others	46/100
9th	Windgap Medical 2011, Boston (United States), Series B	Provider of drug delivery autoinjector for the treatment of anaphylaxis	$76.7M	Taiwania Capital, SKK & 11 others	44/100
10th	Eveon 2009, Montbonnot Saint Martin (France), Seed	Manufacture of connected medical devices focused on the preparation and administration of therapeutic treatment	$4.05M	MEDEVICE, Credit Agricole Alpes Developpement ... & 1 others	42/100